Print

HVTN 114; GOVX-B11

NCT02852005

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID)
AIDSVAX B/E,MVA/HIV62
Adults who previously received MVA/HIV62B in DNA/MVA or MVA/MVA vaccine regimens in the HVTN 205 study.
RandD/trials/Lists/ClinicalTrialsList
4/1/2018
Protein Env B,E; Pox Gag, Evn, Pol B
MVA/HIV62B vaccine in their left deltoid at Months 0 and 4. They will receive placebo in their right deltoid at Months 0 and 4. OR the MVA/HIV62B vaccine in their left deltoid at Months 0 and 4. They will receive the AIDSVAX B/E vaccine in their right del